Combined EGFR/ALK Expression Analysis in Laryngeal Squamous Cell Carcinoma

被引:8
|
作者
Politi, Anastasia [1 ]
Tsiamb, Evangelos [2 ]
Mastronikolis, Nicholas S. [3 ]
Peschos, Dimitrios [4 ]
Asproudis, Ioannis [5 ]
Kyrodimos, Efthymios [6 ]
Armata, Ilianna E. [7 ]
Chrysovergis, Aristeidis [6 ]
Asimakopoulos, Asimakis [8 ]
Papanikolaou, Vasileios S. [6 ]
Batistatou, Anna [9 ]
Ragos, Vasileios [10 ]
机构
[1] Univ Ioannina, Med Sch, Dept Oncol, Ioannina, Greece
[2] 401 GAH, Dept IHC & Mol Biol, Athens, Greece
[3] Univ Patras, Med Sch, ENT Dept, Patras, Greece
[4] Univ Ioannina, Med Sch, Dept Physiol, Ioannina, Greece
[5] Univ Ioannina, Med Sch, Dept Ophthalmol, Ioannina, Greece
[6] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, IST ENT Dept, Athens, Greece
[7] Cambridge Univ Hosp, Med Sch, Cambridge, England
[8] Luxembourg Hosp Ctr, ENT Dept, Luxembourg, Luxembourg
[9] Univ Ioannina, Med Sch, Dept Pathol, Ioannina, Greece
[10] Univ Ioannina, Med Sch, Dept Maxillofacial, Ioannina, Greece
来源
IN VIVO | 2019年 / 33卷 / 03期
关键词
Carcinoma; larynx; EGFR; ALK; GROWTH-FACTOR RECEPTOR; CANCER; ALK; NECK; HEAD; MET; SURVIVAL; GENE;
D O I
10.21873/invivo.11544
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Epidermal growth factor receptor (EGFR) acts as an oncogene in malignancies. Our aim was to examine the role of combined EGFR/ anaplastic lymphoma kinase (ALK) expression as molecular markers in laryngeal squamous cell carcinoma (LSCC) patients. Materials and Methods: Fifty (n=50) tissue sections derived from twenty-five (n=25) primary LSCCs were analyzed by immunohistochemistry (IHC). Results: EGFR overexpression was observed in 17/25 (68%) cases. Concerning ALK, 23/25 (92%) demonstrated low expression. EGFR expression was associated with grade (p=0.049), whereas ALK expression was correlated with stage (p=0.048). ALK overexpression was detected at advanced-stage EGFR-positive cases. A biphasic EGFR protein expression pattern was observed in five (n=5) LSCC cases, whereas ALK expression was stable in all cases. Conclusion: EGFR overexpression is frequently observed in LSCC combined with low ALK expression. LSCC patients with EGFR/ALK protein overexpression should be eligible for targeted therapeutic strategies.
引用
收藏
页码:815 / 819
页数:5
相关论文
共 50 条
  • [31] Analysis of microsatellite instability in laryngeal squamous cell carcinoma
    Garcia Martinez, Jorge
    Perez-Escuredo, Jhudit
    Garcia-Carracedo, Dario
    Alonso-Guervos, Marta
    Suarez-Nieto, Carlos
    Luis Llorente-Pendas, Jose
    Alvarez-Marcos, Cesar
    Hermsen, Mario
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2012, 63 (02): : 79 - 84
  • [32] Co-targeting ALK and EGFR parallel signaling in oral squamous cell carcinoma
    Gonzales, Cara B.
    De La Chapa, Jorge J.
    Saikumar, Pothana
    Singha, Prajjal K.
    Dybdal-Hargreaves, Nicholas F.
    Chavez, Jeffery
    Horning, Aaron M.
    Parra, Jamie
    Kirma, Nameer B.
    ORAL ONCOLOGY, 2016, 59 : 12 - 19
  • [33] Efficacy of Targeted Inhibitors in Metastatic Lung Squamous Cell Carcinoma With EGFR or ALK Alterations
    Lewis, Whitney E.
    Hong, Lingzhi
    Mott, Frank E.
    Simon, George
    Wu, Carol C.
    Rinsurongkawong, Waree
    Lee, J. Jack
    Lam, Vincent K.
    Heymach, John V.
    Zhang, Jianjun
    Le, Xiuning
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (11):
  • [34] EGFR expression in lung squamous cell carcinoma and correlation with prognosis
    Vuckovic, L.
    Latinovic, Tadic L.
    Eri, Z.
    Savjak, D.
    Nenezic, T.
    Vukmirovic, F.
    Golubovic, M.
    VIRCHOWS ARCHIV, 2009, 455 : 355 - 355
  • [35] ALK Protein Expression Patterns in Squamous Cell Carcinoma of the Oral Cavity
    Chrysovergis, Aristeidis
    Papanikolaou, Vasileios
    Mastronikolis, Nicholas
    Tsiambas, Evangelos
    Katsinis, Spyros
    Manoli, Arezina
    Papouliakos, Sotirios
    Ragos, Vasileios
    Pantos, Pavlos
    Peschos, Dimitrios
    Mastronikolis, Stylianos
    Fotiades, Panagiotis
    Mamoulidis, Panagiotis
    Spyropoulou, Despoina
    Kyrodimos, Efthymios
    IN VIVO, 2022, 36 (03): : 1144 - 1149
  • [36] EGFR over-expression in squamous cell carcinoma of the penis
    Wood, L.
    Lavens, N.
    Gupta, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] ALK expression in metastatic cutaneous squamous cell carcinoma: A pilot study
    Lobl, M. B.
    Georgesen, C.
    Black, J.
    Lum, M.
    Lauer, S.
    Whitley, M. J.
    Wysong, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S142 - S142
  • [38] Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma
    Diniz-Freitas, M.
    Garcia-Caballero, T.
    Antunez-Lopez, J.
    Gandara-Rey, J. M.
    Garcia-Garcia, A.
    ORAL DISEASES, 2007, 13 (03) : 285 - 290
  • [39] EGFR mutation and protein expression analysis in sinonasal inverted papilloma and squamous cell carcinoma
    Cabal, Virginia N.
    Menendez, Marta
    Potes-Ares, Sira
    Vivanco, Blanca
    Suarez-Fernandez, Laura
    Riobello, Cristina
    Garcia-Marin, Rocio
    Lopez, Fernando
    Luis Llorente, Jose
    Hermsen, Mario
    CANCER RESEARCH, 2019, 79 (13)
  • [40] Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma
    Ayaz, Lokman
    Gorur, Aysegul
    Yaroglu, Hatice Yildirim
    Ozcan, Cengiz
    Tamer, Lulufer
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (09) : 1499 - 1506